Skip to main content
Top

Policy brief Belgian EBCP Mirror Group patient and citizen engagement

  • Open Access
  • 01-12-2024
  • Commentary
Published in:

Abstract

Rights, preferences, needs and expectations of patients and citizens can only be respected and addressed if they are well understood. As such, a continuous, systematic and formalised dialogue between patients, citizens and policy makers is required to ensure ethical and socially appropriate cancer prevention, diagnostics, treatment and care. Relying on donations and project-based funding is not a sustainable way to ensure patient involvement and representativeness in policy. Patient organizations need long term, structural support to fulfil their role as patient representatives and support network in order to deliver the best possible service and to play their role as a professional representative of their disease-specific community. Inequalities can only be tackled if they are properly identified. This requires the definition of appropriate determinants fit for (inter)national comparison and extension and linkage of good quality data registries for cancer that allow the monitoring these inequalities.
Title
Policy brief Belgian EBCP Mirror Group patient and citizen engagement
Authors
Wannes Van Hoof
Gabrielle Schittecatte
the Thematic Working Group on Patient & Citizen Engagement
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Archives of Public Health / Issue Special Issue 1/2024
Electronic ISSN: 2049-3258
DOI
https://doi.org/10.1186/s13690-024-01370-w
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video

Keynote webinar | Spotlight on innovations in retinal disease

Retinal diseases are a significant cause of vision impairment and blindness worldwide, but the diagnostic and treatment landscape is rapidly evolving. Explore groundbreaking advances in retinal imaging and gene therapy, before taking a deep dive into emerging treatments for wet AMD.

Prof. Giuseppe Querques
Prof. Dr.med. Katarina Stingl
Dr. Miklos Schneider
Watch now
Video
Image Credits
Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images, Close-up of eye during optical coherence tomography for high-resolution retinal imaging and diagnostics/© Lucija / Generated with AI / Stock.adobe.com (symbolic image with model)